TGTX logo

TG Therapeutics, Inc. (TGTX)

Profile

Full Name

TG Therapeutics, Inc.

Ticker

NASDAQ: TGTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 3, 2010

Indexes

Not included

Website

http://www.tgtherapeutics.com

Employees

352

Key Details

Price

$37.09(-1.55%)

Market cap

$5.89B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$329.00M(+40.80% YoY)

Annual EPS

$0.15(+66.67% YoY)

PE ratio

154.52

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $37.09
    TGTX price is $37.09

    30-Day Relative Volume

    0.58
    TGTX 30-day relative volume is 0.58

    Price Performance

    Price Most recent change

    -1.55%
    TGTX price was down -1.55% on Jul 11, 2025

    Price YTD change

    +23.21%
    TGTX price is up +23.21% since January 1st

    Price 1-year change

    +73.38%
    TGTX price is up +73.38% year-on-year

    Price 3-year change

    +614.55%
    TGTX price is up +614.55% over the past 3 years

    Price Range

    Price All-time high

    $233.44
    TGTX price is currently -84.11% below its historical high of $233.44

    Price 3-year low

    $4.86
    TGTX price is currently +663.07% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $5.89B
    TGTX market capitalization is $5.89 billion

    Market cap 3-year change

    +681.49%
    TGTX market capitalization is up +681.49% over the past 3 years

    Market cap All-time high

    $7.63B
    TGTX market capitalization is currently -22.87% below its historical high of $7.63 billion

    Market cap sector rank

    89.5%
    TGTX market capitalization is higher than 89.5% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.53%
    TGTX shares outstanding is up +2.53% year-on-year

    Shares Outstanding 3-Year Change

    +9.37%
    TGTX shares outstanding is up +9.37% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.89
    TGTX beta is 0.89

    200-day SMA

    $32.98
    TGTX price is currently +12.43% above its 200-day simple moving average

    50-day SMA

    $36.59
    TGTX price is currently +1.36% above its 50-day simple moving average

    RSI

    51.83
    TGTX 14-day relative strength index is 51.83

    Volume

    0.58
    TGTX 30-day relative volume is 0.58

    ATR

    $1.34
    TGTX average true range is $1.34

    10-day Historical Volatility

    45.69%
    TGTX 10-day historical volatility is 45.69%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $329.00M
    TGTX annual revenue is $329.00 million

    Revenue Analysts estimate

    $596.09M
    TGTX annual revenue is currently -44.81% lower than the consensus analysts' forecast

    Revenue 1-year change

    +40.8%
    TGTX annual revenue is up +40.8% year-on-year

    Revenue Sector rank

    69.19%
    TGTX annual revenue is higher than 69.19% of companies in Healthcare sector

    EPS

    EPS

    $0.15
    TGTX annual earnings per share is $0.15

    EPS Analysts estimate

    $0.95
    TGTX annual earnings per share is currently -84.24% lower than the consensus analysts' forecast

    EPS 1-year change

    +66.67%
    TGTX annual earnings per share is up +66.67% year-on-year

    EPS Sector rank

    84.11%
    TGTX annual earnings per share is higher than 84.11% of companies in Healthcare sector

    Profit

    Gross profit

    $290.52M
    TGTX annual gross profit is $290.52 million

    Gross margin

    88.30%
    TGTX annual gross profit margin is 88.30%

    Operating profit

    $41.93M
    TGTX annual operating income is $41.93 million

    Operating margin

    12.74%
    TGTX annual operating profit margin is 12.74%

    Net income

    $23.38M
    TGTX annual net profit is $23.38 million

    Net margin

    7.11%
    TGTX annual net profit margin is 7.11%

    Expenses

    Total expenses

    $287.07M
    TGTX annual total expenses is $287.07 million

    Operating expenses

    $248.59M
    TGTX annual total operating expenses is $248.59 million

    Cost of goods sold

    $38.49M
    TGTX annual cost of goods sold is $38.49 million

    Selling, general & administrative expenses

    $154.30M
    TGTX annual SGA is $154.30 million

    Depreciation and amortization

    $280.00K
    TGTX annual depreciation & amortization is $280.00 thousand

    Interest expense

    $24.03M
    TGTX annual interest expense is $24.03 million

    Income tax

    $2.21M
    TGTX annual income tax is $2.21 million

    EBIT & EBITDA

    EBIT

    $49.62M
    TGTX annual earnings before interest & taxes is $49.62 million

    EBITDA

    $49.90M
    TGTX annual EBITDA is $49.90 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $577.69M
    TGTX annual total assets is $577.69 million

    Non current assets

    $11.33M
    TGTX annual long term assets is $11.33 million

    Current assets

    $566.36M
    TGTX annual total current assets is $566.36 million

    Cash and cash equivalents

    $179.89M
    TGTX annual cash & cash equivalents is $179.89 million

    Accounts receivable

    $129.19M
    TGTX annual accounts receivable is $129.19 million

    Inventory

    $110.46M
    TGTX annual inventory is $110.46 million

    Liabilities

    Total liabilities

    $355.33M
    TGTX annual total liabilities is $355.33 million

    Long term liabilities

    $264.65M
    TGTX annual total long term liabilities is $264.65 million

    Current liabilities

    $90.68M
    TGTX annual total current liabilities is $90.68 million

    Accounts payable

    -
    TGTX annual accounts payable value is unknown

    Debt

    Total debt

    $253.72M
    TGTX annual total debt is $253.72 million

    Total debt 1-year change

    +129%
    TGTX annual total debt is up +129% year-on-year

    Long term debt

    $252.56M
    TGTX annual long term debt is $252.56 million

    Short term debt

    $1.16M
    TGTX annual short term debt is $1.16 million

    Equity & Capital

    Shareholders equity

    $222.36M
    TGTX annual stockholders equity is $222.36 million

    Book value

    $222.36M
    TGTX annual book value is $222.36 million

    Retained earnings

    -$1.53B
    TGTX annual retained earnings is -$1.53 billion

    Working capital

    $475.68M
    TGTX annual working capital is $475.68 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$40.52M
    TGTX annual cash flow from operations is -$40.52 million

    Cash from operations 1-year change

    -28.98%
    TGTX annual cash flow from operations is down -28.98% year-on-year

    Cash from investing

    -$1.04M
    TGTX annual cash flow from investing activities is -$1.04 million

    Cash from investing 1-year change

    +97.95%
    TGTX annual cash flow from investing activities is up +97.95% year-on-year

    Cash from financing

    $128.53M
    TGTX annual cash flow from financing activities is $128.53 million

    Cash from financing 1-year change

    +76.78%
    TGTX annual cash flow from financing activities is up +76.78% year-on-year

    CAPEX

    CAPEX

    $45.00K
    TGTX annual capital expenditures is $45.00 thousand

    CAPEX 1-year change

    -
    TGTX annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$40.56M
    TGTX annual free cash flow is -$40.56 million

    Free cash flow 1-year change

    -29.12%
    TGTX annual free cash flow is down -29.12% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    88.30%
    TGTX annual gross profit margin is 88.30%

    Operating margin

    12.74%
    TGTX annual operating profit margin is 12.74%

    Net margin

    7.11%
    TGTX annual net profit margin is 7.11%

    ROA & ROE

    ROA

    5.15%
    TGTX annual return on assets is 5.15%

    ROE

    12.21%
    TGTX annual return on equity is 12.21%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    154.52
    TGTX price to earnings ratio is 154.52

    PE ratio Sector rank

    95.77%
    TGTX price to earnings ratio is higher than 95.77% of companies in Healthcare sector

    PB Ratio

    PB ratio

    24.81
    TGTX price to book ratio is 24.81

    PB ratio Sector rank

    96.69%
    TGTX price to book ratio is higher than 96.69% of companies in Healthcare sector

    PS Ratio

    PS ratio

    15.24
    TGTX price to sales ratio is 15.24

    PS ratio Sector rank

    82.57%
    TGTX price to sales ratio is higher than 82.57% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $5.76B
    TGTX enterprise value is $5.76 billion

    Enterprise value Sector rank

    88.75%
    TGTX enterprise value is higher than 88.75% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    81.69
    TGTX EV/EBITDA is 81.69

    EV/EBITDA Sector rank

    98.42%
    TGTX EV/EBITDA is higher than 98.42% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    6.25
    TGTX annual current ratio is 6.25

    Quick ratio

    5.03
    TGTX annual quick ratio is 5.03

    Leverage

    Debt to equity

    1.10
    TGTX annual debt to equity ratio is 1.10

    Interest coverage ratio

    2.07
    TGTX annual interest coverage ratio is 2.07

    Risk & Stability

    Piotroski F-Score

    4
    TGTX piotroski f-score is 4

    Altman Z-Score

    8.08
    TGTX altman z-score is 8.08

    Analyst ratings

    Recent major analysts updates

    Mar 4, 25 HC Wainwright & Co.
    Buy
    Jan 15, 25 HC Wainwright & Co.
    Buy
    Nov 25, 24 JP Morgan
    Overweight
    Nov 5, 24 HC Wainwright & Co.
    Buy
    Nov 5, 24 Goldman Sachs
    Neutral
    Oct 29, 24 TD Cowen
    Buy
    Sep 18, 24 HC Wainwright & Co.
    Buy
    Aug 7, 24 Goldman Sachs
    Neutral
    Aug 7, 24 B. Riley Securities
    Buy
    Aug 6, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with TGTX included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    High revenue growth stocks
    Healthcare sector
    • What is the ticker symbol for TG Therapeutics, Inc.?
    • Does TG Therapeutics, Inc. pay dividends?
    • What sector is TG Therapeutics, Inc. in?
    • What industry is TG Therapeutics, Inc. in?
    • What country is TG Therapeutics, Inc. based in?
    • When did TG Therapeutics, Inc. go public?
    • Is TG Therapeutics, Inc. in the S&P 500?
    • Is TG Therapeutics, Inc. in the NASDAQ 100?
    • Is TG Therapeutics, Inc. in the Dow Jones?
    • When was TG Therapeutics, Inc.'s last earnings report?
    • When does TG Therapeutics, Inc. report earnings?

    What is the ticker symbol for TG Therapeutics, Inc.?

    The ticker symbol for TG Therapeutics, Inc. is NASDAQ:TGTX

    Does TG Therapeutics, Inc. pay dividends?

    No, TG Therapeutics, Inc. does not pay dividends

    What sector is TG Therapeutics, Inc. in?

    TG Therapeutics, Inc. is in the Healthcare sector

    What industry is TG Therapeutics, Inc. in?

    TG Therapeutics, Inc. is in the Biotechnology industry

    What country is TG Therapeutics, Inc. based in?

    TG Therapeutics, Inc. is headquartered in United States

    When did TG Therapeutics, Inc. go public?

    TG Therapeutics, Inc.'s initial public offering (IPO) was on May 3, 2010

    Is TG Therapeutics, Inc. in the S&P 500?

    No, TG Therapeutics, Inc. is not included in the S&P 500 index

    Is TG Therapeutics, Inc. in the NASDAQ 100?

    No, TG Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is TG Therapeutics, Inc. in the Dow Jones?

    No, TG Therapeutics, Inc. is not included in the Dow Jones index

    When was TG Therapeutics, Inc.'s last earnings report?

    TG Therapeutics, Inc.'s most recent earnings report was on May 5, 2025

    When does TG Therapeutics, Inc. report earnings?

    The next expected earnings date for TG Therapeutics, Inc. is August 6, 2025
    On this page